Accéder au contenu
Merck

Osteopontin drives retinal ganglion cell resiliency in glaucomatous optic neuropathy.

Cell reports (2023-08-25)
Mengya Zhao, Kenichi Toma, Benyam Kinde, Liang Li, Amit K Patel, Kong-Yan Wu, Matthew R Lum, Chengxi Tan, Jody E Hooper, Arnold R Kriegstein, Anna La Torre, Yaping Joyce Liao, Derek S Welsbie, Yang Hu, Ying Han, Xin Duan
RÉSUMÉ

Chronic neurodegeneration and acute injuries lead to neuron losses via diverse processes. We compared retinal ganglion cell (RGC) responses between chronic glaucomatous conditions and the acute injury model. Among major RGC subclasses, αRGCs and intrinsically photosensitive RGCs (ipRGCs) preferentially survive glaucomatous conditions, similar to findings in the retina subject to axotomy. Focusing on an αRGC intrinsic factor, Osteopontin (secreted phosphoprotein 1 [Spp1]), we found an ectopic neuronal expression of Osteopontin (Spp1) in other RGCs subject to glaucomatous conditions. This contrasted with the Spp1 downregulation subject to axotomy. αRGC-specific Spp1 elimination led to significant αRGC loss, diminishing their resiliency. Spp1 overexpression led to robust neuroprotection of susceptible RGC subclasses under glaucomatous conditions. In contrast, Spp1 overexpression did not significantly protect RGCs subject to axotomy. Additionally, SPP1 marked adult human RGC subsets with large somata and SPP1 expression in the aqueous humor correlated with glaucoma severity. Our study reveals Spp1's role in mediating neuronal resiliency in glaucoma.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps monoclonal anti-protéine acide fibrillaire gliale (GFAP) antibody produced in mouse, clone G-A-5, ascites fluid
Sigma-Aldrich
Anti-CD44 Rat mAb (A020), liquid, clone A020, Calbiochem®